Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Silexion Therapeutics Corp (SLXN) had Cash Flow from Investing Activities of $-0.02M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-16.44M |
|
-- |
|
-- |
|
$12.57M |
|
$-12.57M |
|
$-3.94M |
|
$-16.51M |
|
$-16.51M |
|
$-16.52M |
|
$-16.52M |
|
$-16.52M |
|
$-16.52M |
|
$-12.57M |
|
$-12.55M |
|
0.04M |
|
0.04M |
|
$-395.20 |
|
$-395.20 |
|
| Balance Sheet Financials | |
$2.25M |
|
$0.03M |
|
$0.61M |
|
$2.86M |
|
$3.52M |
|
$2.96M |
|
$3.33M |
|
$6.85M |
|
$-3.99M |
|
$-3.99M |
|
$-3.99M |
|
0.12M |
|
| Cash Flow Statement Financials | |
$-8.40M |
|
|
Cash Flow from Investing Activities |
$-0.02M |
$5.10M |
|
$4.64M |
|
$1.27M |
|
$-3.38M |
|
$5.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.64 |
|
-- |
|
-- |
|
-2.88 |
|
-0.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
414.11% |
|
414.11% |
|
-576.98% |
|
1606.91% |
|
$-32.34 |
|
$-202.30 |
|
$-201.78 |
|